3 Stocks Pushing The Wholesale Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 8 points (0.0%) at 17,140 as of Wednesday, Sept. 17, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,738 issues advancing vs. 1,242 declining with 174 unchanged.

The Wholesale industry currently sits up 0.2% versus the S&P 500, which is unchanged. A company within the industry that fell today was LKQ ( LKQ), up 0.9%. A company within the industry that increased today was Airgas ( ARG), up 0.5%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Fastenal ( FAST) is one of the companies pushing the Wholesale industry lower today. As of noon trading, Fastenal is down $0.29 (-0.6%) to $45.53 on light volume. Thus far, 340,413 shares of Fastenal exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $45.48-$46.04 after having opened the day at $45.94 as compared to the previous trading day's close of $45.82.

Fastenal Company, together with its subsidiaries, operates as a wholesaler and retailer of industrial and construction supplies in the United States, Canada, and internationally. The company offers fasteners and other industrial and construction supplies under the Fastenal name. Fastenal has a market cap of $13.6 billion and is part of the services sector. Shares are down 3.6% year-to-date as of the close of trading on Tuesday. Currently there are 4 analysts that rate Fastenal a buy, 1 analyst rates it a sell, and 5 rate it a hold.

TheStreet Ratings rates Fastenal as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Fastenal Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, AmerisourceBergen ( ABC) is down $0.53 (-0.7%) to $76.58 on average volume. Thus far, 524,174 shares of AmerisourceBergen exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $76.46-$77.29 after having opened the day at $77.25 as compared to the previous trading day's close of $77.11.

AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. AmerisourceBergen has a market cap of $17.2 billion and is part of the services sector. Shares are up 9.7% year-to-date as of the close of trading on Tuesday. Currently there are 8 analysts that rate AmerisourceBergen a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates AmerisourceBergen as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and poor profit margins. Get the full AmerisourceBergen Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Cardinal Health ( CAH) is down $0.47 (-0.6%) to $75.08 on average volume. Thus far, 724,144 shares of Cardinal Health exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $75.05-$75.74 after having opened the day at $75.74 as compared to the previous trading day's close of $75.55.

Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. Cardinal Health has a market cap of $25.2 billion and is part of the services sector. Shares are up 13.1% year-to-date as of the close of trading on Tuesday. Currently there are 12 analysts that rate Cardinal Health a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Cardinal Health as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Cardinal Health Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the wholesale industry could consider iShares Dow Jones US Cons Goods ( IYK) while those bearish on the wholesale industry could consider ProShares Ultra Sht Consumer Goods ( SZK).

null

More from Markets

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Video: Stop Using Student Loan Money to Buy Bitcoin

Video: Stop Using Student Loan Money to Buy Bitcoin

Let the Najarian Brothers Crash-Proof Portfolio

Let the Najarian Brothers Crash-Proof Portfolio

Facebook Sends Facial Recognition Notification in Error

Facebook Sends Facial Recognition Notification in Error

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists